Advertisement

Topics

Capital Royalty L.P. Company Profile

16:46 EST 18th November 2017 | BioPortfolio

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalty has the market knowledge and financial know how necessary to help you maximize the value of your royalty interest.

Location

1000 Main, Suite 2500
Houston
Texas
77002
United States of America

Contact

Phone: (713) 209-7350
Fax: (713) 209-7351
Email: jwebster@capitalroyalty.com


News Articles [432 Associated News Articles listed on BioPortfolio]

Paul Capital Partners: Growth Capital Providers for the Biotech Industry

In this interview, filmed during the recent BIO conference in San Diego, Fintan Walton speaks with Ken Macleod, partner in the well-known Paul Capital Partners, located in London. He tells how the com...

PDL BioPharma Updates Presentation Time for Cantor Fitzgerald Conference

INCLINE VILLAGE, Nev., Sept. 19, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's chief executive officer, will present at the 2017 Can...

Coming In Tuesday's "The Pink Sheet" DAILY - Royalty Pharma Makes A Move For Elan

Royalty Pharma’s $11 per-share bid for Elan is too low, according to Elan’s management and industry analysts.

PharmaVentures: Valuation methods and trends in licensing deals

In this informative panel discussion, Fintan Walton talks with 3 members of PharmaVentures’ deal advisory team about Royalty Rates, particularly the valuation of deals in the pharmaceutical and biot...

PDL BioPharma (PDLI) - Depomed paying off

Edison Investment Research - Pharmaceutical & healthcare - PDL BioPharma: PDL BioPharma recently reported strong Q217 earnings mainly due to royalties related to the authorized generic of Glumetza as ...

PDL BioPharma Announces New $25 Million Share Repurchase Program

INCLINE VILLAGE, Nev., Sept. 25, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) announced today that PDL's board of directors has authorized a new stock repurchase p...

Soligenix Announces Closing of $5,115,000 Concurrent Registered Direct Offering and Private ...

Lead investors in the financing included Knoll Capital Management, LP and ACT Capital Management, LLLP. Aegis Capital Corp. acted as the sole placement agent for Read more...

Sinovac scooped up by consortium and becomes private

Vaccines developer Sinovac Biotech Ltd. is being acquired by a consortium consisting of the company's president and CEO Yin, SAIF, C-Bridge Capital, Advantech Capital, and Vivo Capital.

PubMed Articles [110 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Perceptions of community, social capital, and how they affect self-reported health: a multilevel analysis.

The link between social capital and self-reported health has been widely explored. On the other hand, we know less about the relationship between social capital, community socioeconomic characteristic...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Invited Commentary. The Royalty of Evidence: The Randomized Control Trials.

Clinical Trials [34 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Treatment of Sub-Capital Fractures of Hip Joint by Using TriboFit™ Acetabular Buffer

The purpose of this study is to determine the performance and efficacy during 6 and 12 month post operation. 1. determine changes in patient pain level 2. determine changes in ...

Companies [1040 Associated Companies listed on BioPortfolio]

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

DRUG ROYALTY CORPORATION INC

A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

DRI Capital Inc.

DRI is a pioneer and global leader in healthcare royalty investing and has completed transactions with large global pharmaceutical companies, biotechnology companies, universities...

Drug Royalty

Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...

HealthCare Royalty Partners

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billio...

More Information about "Capital Royalty L.P." on BioPortfolio

We have published hundreds of Capital Royalty L.P. news stories on BioPortfolio along with dozens of Capital Royalty L.P. Clinical Trials and PubMed Articles about Capital Royalty L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Capital Royalty L.P. Companies in our database. You can also find out about relevant Capital Royalty L.P. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record